Project Report on Zensar Pharma

8/3/2019 Project Report on Zensar Pharma

1/88

A SUMMER TRAINING PROJECT REPORT

ON

COMPARATIVE STUDY OF ZENSAR PHARMACEUTICALS

For the partial fulfillment of Master of Business Administration Program

UNDER THE GUIDANCE OF SUBMITTED BY :

Dr. Vinitendra Pratap Singh Mohammad Shairan

(HOD, MBA) MBA IIIrd Sem.

B.N. College of Engineering & Technology, Lucknow

(Affiliated to Gautam Buddh Technical University)

Session: 2011-2012

1


2/88

TABLE OF CONTENT

ACKNOWLEDGEMENT

OBJECTIVES & SCOPE OF THE STUDY

PART- I

Introduction

Company Profile

Services/Products provided by the company

Introduction to the topic

Analysis of the topic

Part- II

Research Methadology

Findings

Graphs

Data Analysis

Limitations

Conclusions

Suggestions & Recommendations

Bibliography

Appendix

2


3/88

ACKNOWLEDGEMENT

Like most endeavors, preparing this project was a collaborative effort. I owe a great debtto many individuals who helped me in successful completion of this project.

I would like to express my sincere gratitude to COMPANY NAME for giving me an

opportunity to complete my summer internship program in their esteemed organization.

I would not have completed this journey without the help, guidance and constant support

and co-operation of certain people who acted as guides and friends along the way, I would

like to express my deepest and sincere thanks to Dr. UPAMA Mishra ( Director , B.N.

College of Engineering & Technology) , Dr. Vinitendra Pratap Singh ( H.O.D. ,

M.B.A. Department), and for their invaluable guidance and help. The project could not

have been completed without their support and guidance.

In this connection I would like to express my gratitude to my parents and friends who

were constant source of inspiration during my summer training project report. At last I

thank to Almighty for giving me the power to complete this project successfully.

Mohammad Shairan

MBA IInd year

3


4/88

OBJECTIVE OF STUDY

The key objectives of the Study are as follows:

To assess the build up in brand health of Zensar and the impact of the

communication to answer the questions

Is the advertising creating awareness and saliency for the brand?

Is advertising being noticed?

Is the message been picked up and comprehended?

Is the brand been integrated with the message? Is the brand communication created a favorable disposition for the

brand?

4


5/88

COMPANY PROFILE

Ranbaxy, a leading name in pharma and healthcare has recently started a new

initiative in OTC drugs, with a focus to take advantage of the growing Rs

3000 crore OTC market in India. This new division is called Ranbaxy Global

Consumer Healthcare. Some of the erstwhile schedule H brands that have

been transferred to the OTC umbrella include Zensar, Pepfiz, Garlic Pearls

and Gesdyp. Zensar enjoys the flagship brand status among the switch

brands

The OTC brand of Zensar is being supported with a TV ad campaign

involving three creatives. Spends have been made on both C&S and

Doordarshan channels.

The Brand

Zensar is a comprehensive daily food supplement that has a balanced

combination of vitamins, minerals & ginseng.

Zensar was launched in 1989 as a prescription drug. The drug was promoted

as a product for energy enhancement, anti-stress and fighting fatigue, which

emanated from its key ingredient Ginseng.

However with the market dynamics changing with the rise of anti oxidant

category in prescriptions, prescription share of Zensar dropped through the

nineties. The brand however retained its volumes owing to consumers buying

it over the counter.

In 1999, it was taken off Schedule H of the drug controllers and became an

OTC product. Its currently classified as a food supplement.

5


6/88

Key markets for Zensar include lower population strata towns and rural

markets as well.

The Category

The category, Adult Health Supplements, consists of Zensar, Becosule, other

vitamin capsules, Spirulina, Brahmi and Ashwagandha poppables from

Himalaya and other OTX drugs. (Drugs pushed by the Chemist, even if not

prescribed the doctor) While Zensar faces competion from these drugs, the

penetration of these brands is lowand occasional/ need based use is

predominant. Therefore the marketing task would be category creation,

rather than fighting for share from other players. Usage of these drugs is

usually linked to rejuvenation, energy enhancement, anti oxidant and anti

stress benefits. In terms of pricing, Becosule is a cheaper alternative to

Zensar. RGCH would now like to track the impact of the TV campaign and

other marketing activity on brand health and build up of associations with the

brand in consumer minds.

6


7/88

INDIAN PHARMACEUTICAL COMPANY

The Indian pharmaceutical industry is a success story providing employment

for millions and ensuring that essential drugs at affordable prices are

available to the vast population of this sub-continent.

The Indian Pharmaceutical Industry today is in the front rank of Indias

science-based industries with wide ranging capabilities in the complex field

of drug manufacture and technology. A highly organized sector, the Indian

Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to

9 percent annually. It ranks very high in the third world, in terms of

technology, quality and range of medicines manufactured. From simple

headache pills to sophisticated antibiotics and complex cardiac compounds,

almost every type of medicine is now made indigenously.

The Indian Pharmaceutical sector is highly fragmented with more than

20,000 registered units. It has expanded drastically in the last two decades.

The leading 250 pharmaceutical companies control 70% of the market with

market leader holding nearly 7% of the market share. It is an extremely

fragmented market with severe price competition and government price

control.

The pharmaceutical industry in India meets around 70% of the country's

demand for bulk drugs, drug intermediates, pharmaceutical formulations,

chemicals, tablets, capsules, orals and injectibles. There are about 250 large

units and about 8000 Small Scale Units, which form the core of the

7


8/88

pharmaceutical industry in India (including 5 Central Public Sector Units).

These units produce the complete range of pharmaceutical formulations, i.e.,

medicines ready for consumption by patients and about 350 bulk drugs, i.e.,

chemicals having therapeutic value and used for production of

pharmaceutical formulations

Following the de-licensing of the pharmaceutical industry, industrial

licensing for most of the drugs and pharmaceutical products has been done

away with. Manufacturers are free to produce any drug duly approved by the

Drug Control Authority. Technologically strong and totally self-reliant, the

pharmaceutical industry in India has low costs of production, low R&D

costs, innovative scientific manpower, strength of national laboratories and

an increasing balance of trade. The Pharmaceutical Industry, with its rich

scientific talents and research capabilities, supported by Intellectual Property

Protection regime is well set to take on the international market.

ADVANTAGES

Competent workforce:

India has a pool of personnel with high managerial and technical competence

as also skilled workforce. It has an educated work force and English is

commonly used. Professional services are easily available.

Cost-effective chemical synthesis: Its track record of development,

particularly in the area of improved cost-beneficial chemical synthesis for

various drug molecules is excellent. It provides a wide variety of bulk drugs

and exports sophisticated bulk drugs.

8


9/88

Legal & Financial Framework: India has a 53 year old democracy and

hence has a solid legal framework and strong financial markets. There is

already an established international industry and business community.

Information & Technology: It has a good network of world-class

educational institutions and established strengths in Information Technology.

Globalisation: The country is committed to a free market economy and

globalization. Above all, it has a 70 million middle class market, which is

continuously growing.

Consolidation: For the first time in many years, the international

pharmaceutical industry is finding great opportunities in India. The process

of consolidation, which has become a generalized phenomenon in the world

pharmaceutical industry, has started taking place in India

THE GROWTH SCENARIO

India's US$ 3.1 billion pharmaceutical industry is growing at the rate of 14

percent per year. It is one of the largest and most advanced among the

developing countries.

Over 20,000 registered pharmaceutical manufacturers exist in the country.

The domestic pharmaceuticals industry output is expected to exceed Rs260

billion in the financial year 2002, which accounts for merely 1.3% of the

global pharmaceutical sector. Of this, bulk drugs will account for Rs 54 bn

9


10/88

(21%) and formulations, the remaining Rs 210 bn (79%). In financial year

2001, imports were Rs 20 bn while exports were Rs87 bn.

STEPS TO STRENGTHEN THE INDUSTRY

Indian companies need to attain the right product-mix for sustained future

growth. Core competencies will play an important role in determining the

future of many Indian pharmaceutical companies in the post product-patent

regime after 2005. Indian companies, in an effort to consolidate their

position, will have to increasingly look at merger and acquisition options of

either companies or products. This would help them to offset loss of new

product options, improve their R&D efforts and improve distribution to

penetrate markets.

Research and development has always taken the back seat amongst Indian

pharmaceutical companies. In order to stay competitive in the future, Indian

companies will have to refocus and invest heavily in R&D.

The Indian pharmaceutical industry also needs to take advantage of the

recent advances in biotechnology and information technology. The future of

the industry will be determined by how well it markets its products to several

regions and distributes risks, its forward and backward integration

capabilities, its R&D, its consolidation through mergers and acquisitions, co-

marketing and licensing agreements

Current demand in the Indian pharmaceutical sector stands at about $4 to $5

billion, and is forecast to increase at an annual rate of 15 - 20% in the future.

Nevertheless, average per capita expenditure on pharmaceuticals in India is

10


11/88

only $3 -- compared to $412 in Japan, $222 in Germany and $191 in the US.

This is due in part to the prevalence of alternative healing methods in India,

such as ayurvedic medicine and homeopathy, but also because prices for

drugs have been kept artificially low by the Indian government. In fact,

India's pharmaceutical industry is one of the most highly regulated industries

in the country. Price controls have a strong effect on profitability in the

industry, and weak patent protection poses a long-term threat to investment

in India's drug market. Foreign firms also find it difficult to operate in India

due to arbitrary Bureau of Industrial Cost and Pricing (BICP) pricing

changes, arbitrary local FDA decisions, high import duties (about 42%) and

complex import procedures.

However, while the pharmaceutical sector in India wills most likely stay

regulated in the short term, there are plans for reform. The sheer size and

growth of India's domestic pharmaceutical industry is making it increasingly

difficult for the government to regulate prices for every single firm, and

pressure from the World Trade Organization is also speeding up discussions

within the national government to improve patent protection. As a result,

foreign pharmaceutical firms can expect improved market opportunities in

India's enormous drug market over next several years

11


12/88

MARKET STRUCTURE OF THE INDIAN PHARMACEUTICAL

INDUSTRY

The Indian pharmaceutical industry is highly fragmented -- there are now

more than 20,000 domestic manufacturers of end-use pharmaceuticals,

particularly because of the industry's low capital requirement and the lack of

product patents. Only about 300 of these are in the organized sector. This

structure causes intense competition, especially in the bulk drug markets,

with profitability falling as demand expands.

For value purposes, drugs in India are generally classified into two categories

-- bulk drugs and formulations. Due to India's low overhead costs, bulk drugs

comprise the largest sector in the country's pharmaceutical market. Indias

bulk drug sector also makes up about 6% of the international bulk drug

market. Drug intermediates are used as raw materials for the production of

bulk drugs, which are either sold directly or retained by companies for the

production of formulations. Formulations can be subdivided into generic

drugs and branded or "ethical" drugs, the latter of which are made under

process patent and sold under a separate brand name. Expected short-term

growth for the two types of drugs has been 20% for bulk drugs and 15% for

formulations.

The import of finished pharmaceuticals is almost negligible, and confined to

very specific types like anti-cancer drugs. In 1994, the import of drugs,

pharmaceuticals and intermediates was estimated at $450 million, and

included the following: antibiotics, penicillin and its salts, erythromycin and

its preparations, vitamins and provitamins, vaccines (polio, human and

12


13/88

veterinary), preparations containing insulin, caustic and other hormones, and

tetracycline and its preparations.

Essential drugs comprised of antibiotics, antibacterial, anti-TB, anti-parasitic,

and cardiovascular constitute a major portion of turnover of the industry.

Indian companies dominate this class of drugs with a market share of 71%.

Multinational companies are reluctant to enter these markets as most of them

are under government price controls.

13


14/88

ABOUT THE ZENSAR

Zensar Technologies (Zensar) is a globally renowned software services company that

specializes in providing a complete range ofSoftware Services and Solutions. Zensar is

ranked amongst India's Top 20 Software Services Companiesby National Association of

Software and Services Companies (NASSCOM) and is also recognized by the

Department of Scientific and Industrial Research (DSIR) for its robust in-house Research

and Development practices and an acknowledged leader in Innovation. The Software

services range from the traditional to the transformational Enterprise Product

Implementation and Hosting, Business Intelligence and Data Warehousing, Collaboration

and Knowledge Management Services, Business Process Outsourcing and Optimization,

Remote Infrastructure Management and Testing, and the entire range of Software

Application Planning, Portfolio Building, Development, Migration and Support. Zensar is

the world's first enterprise-wide SEI CMM Level 5 Company and enjoys a strong

presence in the United States, Europe, Africa, Middle East and Asia-Pacific regions.To

service Global Customers, Zensar has Delivery Centers in Pune and Hyderabad in India,

China, Japan and the UK. With 6000+ associates, 400+ customers and 14 nationalities

operating in more than 20 global locations, Zensar helps transform Global Corporations.

14


15/88

Zensar encourages challenging of opinion, of mindsets and a young and

vibrant culture of innovation and experimentation. It consciously focuses on

building diversity into the system whether it is of gender, region, nationality,

background, learning or education, and then in creating a framework for a

confluence of these different ideas, cultures and experiences to make an

authentic global organisation that delivers value to its customers. At Zensar

individual thinking, creativity, innovation and flexibility are celebrated and

through that enormous diversity seeps in a 'world culture' for Zensar to

become true transformation partners to global corporations driven by a set of

core organisational values - that being the only place for homogeneity!

Using the Global Delivery Model in integrating global talent including

customer capabilities, embedding frameworks for service delivery, and by

creating the necessary go-to-market front ends, Zensar demonstrates business

value for its customers! This enables a true customer proximal model by

requirements being captured by a consultant at their end with localized and

business specific capabilities and the luxury of global sourcing and

24X7X365 support and disaggregated software development that leverages

talent across nations.

ZENSAR VALUABLE CLIENTS

Towards creating value to its customers business, Zensar has built and

consolidated a comprehensive portfolio of services in IT and BPO, lending awide range of benefits from cost arbitrage, to unmatched quality,

differentiated value to a holistic strategic partnership with its customers; and

further lending a significant advantage by offering models to customers that

15


16/88

best suit their business needs traversing the context areas down to the core

focus areas of the customer.

Zensar enjoys enduring relationships with global leaders like Cisco,

Assurant, Danaher Corporation, Electronics Arts, iSelect and Logitech,

among several others. Zensar's customers are spread across various industry

segments like Manufacturing, Retail, Banking and Insurance, High-Tech

manufacturing and Connected Services. Zensar has also forged strategic

technology partnerships with global technology leaders such as IBM,

Microsoft, Sun Microsystems and Oracle. These partnerships enable Zensar

to leverage its core competencies, ensuring comprehensive and state-of-the-

art business solutions to its customers.

ZENSAL EXPERTISE

The Company offers industry and business consulting with industry focused

teams in Retail, Manufacturing, Banking, Insurance, Energy and Utilities,

Media and Connected Services (Government, Education and Healthcare),

bringing in best practices culled from individual and combined experiences.

Zensar's decision enabling services lend velocity to the customer's business

by process and technology consulting that help corporations make better

decisions. The services include enablers like business intelligence and data

warehousing, content and collaboration management, and knowledge

management.

The Business Process Outsourcing and Optimisation (BPO2) based

services of Zensar as the name suggests involves process execution and

optimisation to help businesses perform at optimum levels by making

16
http://iselect.com.au/http://iselect.com.au/


17/88

continuous improvements possible. The services in this space span from

accounts payable, receivables, telesales, helpdesk support, to Knowledge

Process Outsourcing on the higher end.

OurIT Enabling Services help companies design, develop, implement and

test applications whether packaged or even custom-built to enable their

business processes. Zensar has a strong engagement with Oracle being their

platinum partner with a 1300+ consultants team; and in the SAP space

offering focused templatised solutions in key verticals of dairy, textile,

pharma, manufacturing and IT/operations and being the largest partner in

certain key segments and markets. Our teams bring a strong blend of

functional business skills and technology or package-specific expertise to

help make swift implementations possible with minimal risk rendering

maximum value.

Zensar's IT Support Services help companies focus on their core of aligning

IT to business needs while letting us take care of the operational

maintenance, fixes and day-to-day support of their applications and

technology infrastructure.

17


18/88

Our Vision

Transformation partners to global corporations.

Our Values

Customer Sovereignty

Our customers are the reason for our existence. We anticipate their needs and

endeavor to meet and surpass their expectations.

Passion For Excellence

We strive to attain individual and team excellence through a spirit of

continuous learning, lofty standards, new ideals and a commitment to high

levels of achievement.

Continuous Innovation

We aspire to seek and create a 'new way.' We will continuously reengineer

our processes and mindsets and encourage individual creativity and

improvisation in all our actions.

Transparency and Integrity

We will nurture a culture of spontaneity and mutual trust. Impeccable ethics

and morals will be the cornerstone of all our interactions and relationships.

People Orientation

We will accord empathy, respect and dignity to every Zensarian. We will

create an environment where every committed and capable member of the

18


19/88

organization is given ample rewards and opportunities for growth.

Social Responsibility

We will recognize, abide by and add value to the social environment, while

embracing our responsibilities as a good corporate citizen in every country

we operate.

GLOBAL DELIVERY PLATFORM

Zensars Global Delivery Platform (GDP) provides collaborative solution

delivery across shores and enterprises seamlessly. The Platform combines

mature off-shoring processes, which emulates industry best practices and a

community of intellect across the globe that spans multiple business domains

using Zensars proprietary Solution Blueprint ( SBP) . SBP enables Zensars

global delivery platform where capabilities of software professionals across

geographies can be leveraged without physically bringing them under one

roof. Using SBP these talented professionals will essentially focuses on

designing whereas SBP would handle the routine software code to generation

activity.

The global delivery platform thus significantly reduces people dependence

and technology bondage to deliver agile, flexible and future-proof solutions

on demand.

Zensars SBP enabled, unique GDM is virtual, and defies the traditional need

for brick and mortar structures to service customers.

These solutions are provided to customers on an Opti-Shore Delivery

Model, often tailored to suit individual customer requirements. The GDP

provides our customers with flexibility, a choice of differentiated services,

access to a global expertise pool, new business channels and provides

software that is standardized and built to last. The GDP also provides access

19


20/88

to world class business and application modeling using a distributed and

collaboration environment enabling Zensar to seamlessly deliver IT-Enabled

Services and Solutions from global locations

20


21/88

ACHIEVEMENTS

Zensar is committed to meet customers' needs and expectations by

delivering competitive IT and Business Process Outsourcing

solutions. This sentiment is evident from our continuous

perseverance to accredit ourselves with globally recognised

industry standards and the awards we are bestowed with by various

global institutions

Golden Peacock Award for CSR - 2011

Zensar Technologies has been selected as the winner of Golden Peacock

Award for Corporate Social Responsibility for the year 2011 by the Awards

Jury, under the Chairmanship of Justice P N Bhagwati, former Chief Justice

of India and Member, UN Human Rights Commission. The Golden Peacock

Awards are recognized worldwide as the hallmark of corporate excellence

because of their independence, integrity, transparency and thorough and open

application process. The Golden Peacock is a very prestigious and well-

known award in the field of CSR in India.

International Association of Outsourcing Professionals

Zensar Technologies was recognized by the International Association of

Outsourcing Professionals (IAOP) among the Top 100 Global OutsourcingCompanies - 2008, 2009, 2010, and 2011. Zensar was also ranked in several

group categories - Best 20 Leaders by Industry Focus Financial Services,

Retail, Manufacturing and Industry Specific Services IAOP 2011.

21


22/88

Named in Global Services 100 list - 2010

Zensar has been recognized as an organization that has reacted well to

changing demands and markets via their career development strategies and

has implemented change management initiatives at its best

Ranked among top 20 IT exporters in India by NASSCOM

Zensar Technologies has been ranked among the top 20 IT Services

Exporters for the year 2009-10 by the National Association of Software andServices Companies (NASSCOM) of India

Investment in People Award 2010

Zensar Technologies was awarded the Asia Responsible Entrepreneurship

Awards (AREA) Investment in People Award 2010 in New Delhi on the

20th of November, 2010 by Enterprise Asia, a non-governmental

organization in pursuit of entrepreneurship development across the region.

Founded by entrepreneurs for entrepreneurs, the organization is supported by

a panel of prominent industry and government leaders who truly believe in

the mission of championing entrepreneurship in Asia. AREA recognizes and

honors Asian Businesses for championing sustainable and responsible

entrepreneurship

22


23/88

CNBC TV 18 International Trade Award-2007, 2008, 2009

In appreciation of its outstanding contribution to Indian trade CNBC-TV 18

has honored Zensar with The Exporter of the Year Award for three years

continuously for wealth creation in India's international trade community

Winner of FICCI's CSR Special Jury Commendation Award

Zensar has been awarded the 'Special Jury Commendation' Award by the

President of India, Dr. A.P.J Abdul Kalam for the outstanding commitment

and contribution to Nation Building through CSR efforts.

Employer Branding Awards 2007-2008

Zensar has been recognized as an organization that has reacted well to

changing demands and markets via their career development strategies and

has implemented change management initiatives at its best

Recognised by the BBB

Zensar has been recognised by the BBB and has received the BBB online

reliability seal. Zensar is now part of core group of businesses that support

ethical business practices and integrity in the market place

Trailblazer of the Year Award for Best HR Practices-2006

In recognition of the outstanding contributions and achievements,

particularly in the field of Human Resource & Development, the National

HRD Network honored us with the Trailblazer of the Year Award from

NHRD for Best HR Practices for 2006Zensar has also been recognized for its

23


24/88

unique HR practices by the Madhya Pradesh government which recently

conferred the Golden Edge Award for Best HR practices for 2006

Corporate Governance Business Award-2006

For its unique contribution to the society, Zensar won the Corporate

Governance Business for Social Responsibility Award for 2006, which was

presented by Bombay Stock Exchange in association with Times Now

24


25/88

SERVICES OFFER

IT Process Consulting

Why do 2 out of 3 Software Projects (66%) fail to deliver within Time, Cost

and Quality parameters?

How will streamlining processes of IT infrastructure and service

management achieve cost benefits; at the same time improve SLA

compliance too?

How to identify and alleviate risk and regulatory non-compliance using

industry accepted Governance framework?

Why Business-IT alignment is still the CIOs top priority?

These are some of the acute problems faced by organizations today, with one

common thread binding them all - immature process. It is the prime cause

for inefficiencies and ineffectiveness. It leads to duplication of work,

inconsistency, lack of common goal, inability to scale up, silo focus, lack of

measurement and improvement and many more.

We, at Zensars ITPC (IT Process Consulting) practice, help you to simplify,

optimize and thus improve maturity of the underlying processes. Our focus is

on

- delivering solutions targeted at enhancing productivity

- improve service and project delivery

- cost optimization

- alignment with industry recognized frameworks/standards using process

solutions

ITPC helps you to achieve the above challenges. This is accomplished using

our proven methodology ProZEN across the areas of IT Service Management

25


26/88

(ITSM), Software Engineering and Quality Assurance, Process Optimization

and IT Governance.

SERVICES OFFERING

Source:www.zensar.com

IT Service Management: To manage IT services and systems

Software Engineering: For maturity of software development and

maintenance

Process Optimization: To achieve best out of your process

IT Governance: To gain efficiency, control, compliance and business

alignment

26


27/88

BEST PRACTICES

Best practices we use are -

IT Infrastructure Library (ITIL) by OGC

Capability Maturity Model Integrated (CMMI) by SEI

People Capability Maturity Model (PCMM) by SEI

Microsoft Operations Framework (MOF) by Microsoft

Control Objective for IT (COBIT) by ISACA

PMBOK by PMI

Six Sigma and Lean

ISO 20000, 27000 and 38500

Business Process Management Suite by OMG

SCAMPI and Goal-Question-Indicator-Measurement by SEI

27


28/88


28


29/88

MARKET METHODOLOGY:

Our Methodology ProZEN is the cornerstone for being able to deliver a

consistent experience to all our customers. It is flexible to suit your need.


ProZEN is a structured yet flexible methodology at each stage, meaning you

can engage us for one or all of the distinct services depending on your needs.

What makes ProZEN unique is the detailed attention it provides for an end to

end process solution while maintaining / retaining customer centricity.

29


30/88

VALUE POSITION

Holistic, more complete view

Our "Multimodal" process improvement provides more flexibility and

agility. We can leverage the differentiating features of each model

Efficiency

Effective & efficient execution using rigor of world class Project

Management built in ProZEN methodology

Effectiveness

Our Assessments, coupled with benefit realization analysis help you

identify the low hanging fruits and long term actions that are tightly

linked with business needs and priorities

Acceleration

Leveraging our own IP and considering your existing initiatives give

you quicker turn around.

Business Benefit RealizationOur structured approach for Organization Change Management speeds

up the adoption rate of the new process and ensures business gain

Cost Advantage

We leverage our offshore team to provide you virtual consultancy very

cost effectively.

Our Consultants

Depth and breadth of our consulting team will provide unsurpassed value to

you. We have qualified consultants certified in - ITIL Managers (EXIN),

CISA (ISACA), 6 Sigma Black Belts, PMP, IDS-Scheer ARIS, SCAMPI(B)

Lead Appraiser and many more.

30


31/88

Impact Sourcing

Despite the uncertain economic outlook and cash flow pressure, Zensar

believes that the current market conditions can provide new opportunities for

organizations that are already outsourcing, or planning to outsource, their

processes and function to reap significant financial and non-financial benefits

in the immediate future. Impact Sourcing is a unique methodology that will

help drive high performance in the near and long term to organizations.

Impact Sourcing assures 10 % cost savings within 10 months by deploying a

best-of-breed COBIT framework & ITIL methodologies to generate a future

roadmap tailored for organizations to meet their optimization needs. We can

bring rigour and discipline to existing business functions and drive value by

fixing distressed and winding processes reducing risk in complex contracts,

and forming partnerships. We help our clients to formulate and implement

strategies, reduce costs, increase efficiency, drive innovation and expand into

new markets with immediate effect to costs

Benefits

Strong lineage in helping organizations create a comprehensive

optimization plan

Phased approach helps organizations identify the 'cost culprits'

Best practices helping organizations benchmark with the industry

Domain expertise, technology and process capabilities coupled with

strong focus on quality deliverables provide added benefits to the

customers in their optimization initiatives.

Information Architecture Services

31


32/88

IA is the art and science of organizing and labeling websites, intranets,

online communities and software to support usability The Information

Architecture Institute

At Zensars IA CoE we constantly strive to ensure the right blend of this art

and science is achieved every time we deliver our IA services which allow

users to achieve their goals efficiently and effectively. Our Usability and IA

services work in unison to provide an unmatched level of user comfort and

content positioning by leveraging the rich experience of our IA architects and

Knowledge Strategists.

IA as we perceive is about the approach/methodology that effectively

structures the unstructured

The IA Practice focuses on the following Service lines:

Business case development

Business Solution Map

Information needs analysis

Information structure and page layouts Creating controlled vocabularies and metadata

Search engine optimization

Enhancing content management systems

Best Fit Technology Implementation-Information Storage, Access &

Delivery Platform

SOFTWARE SERVICES

32


33/88

We help enterprises expand their businesses by Custom Application

development and implementation services that are capable of performing

across multiple platforms and infrastructures. Cost-effectiveness and strong

delivery capabilities in Agile and Waterfall Methodologies are at the focus of

our application development and maintenance strategy. Our

matured application development services encompass all the phases of

Software Development Life Cycle (SDLC), starting from translating business

needs into project requirements through implementation and post-production

user support. With a rich experience of providing cost effective and quality

custom application development services and solutions capable of consistent

performance, Zensar can provide rapid adaptation- with minimal

interruptions in the current processes and has worked with a Fortune 500

clientele worldwide.

33


34/88

Value Proposition

Use of home grown Solution BluePrint (SBP)framework during various

phases of application development

Use of Global Delivery Model

Focus on using re-usable components and tools reducing cycle time

and costs

Alliances with reputed technology firms (Microsoft GOLD certified

partner, Oracle Certified partner)

Knowledge acquisition and retention using CMMI processes

Application Support & Maintenance

In the software lifecycle, nearly 70% of the cost goes into Application

Support & Maintenance activities. Research suggests that large enterprises

spend an average of 73% of their IT budget on Application Maintenance of

existing system. Clearly, Application Management presents high potential

for cost savings in global enterprises.

Zensar's expertise in Application support and maintenance has seen a long

list of partnerships with fortune 500 customers for more than a decade,

Zensar offers a cost effective solution to customers through

Focus on performance measures and continuous improvement besides

Service Level Agreements (SLAs)

Timely resolution of issues and root cause analysis of each issue

Established support matrix offering Help Desk services and

34
http://www.solution-blueprint.com/http://www.solution-blueprint.com/


35/88

Multi-level maintenance process using a Corrective, Preventive,

Adaptive & Perfective approach

Best Practices

Continuous improvement in application support and maintenance

services with objective of lowering Total Cost of Ownership (TCO)

Established practice focusing on defining / improving processes

Feedback of lessons learned from projects to practice for wider

implementation

Generating knowledge repository of issues / resolution for futurereferences.

Value Proposition

Experience in supporting mission critical / business critical application

for fortune 500 customers

Decade long relationship with most of our customers

Single window for providing application maintenance and support

with infrastructure management

Providing continuous improvement against industry standards and

benchmark

Binding SLA framework with Critical Service Level (CSL) and

Quality Process Processes in line with ISO 9000 Standards and the SEI-CMMI

framework

35


36/88

User Experience Solutions

Low conversion rates on your ecommerce site?

High transaction failures on your net banking site?

Poor user experience could be the barrier to your websites success

Click the button below for a FREE Assessment of your site

Zensars User Experience team helps you create positive and

impactful experiences for your users. We design simple and effective

interfaces for software applications, products, websites or mobiles

Best Practices

Some best practices we ensure in our approach to any project

Involve end users in the design process, to the extent possible

Use lo-fidelity prototyping extensively to set the tone for the UI

requirements

Encourage iterative mode of prototyping to get it right!

Our HTML aligns with W3C priority 1 accessibility guidelines

Use informal methods of usability testing to give users a comfort

feeling

Value Proposition

User adoption is at highest levels - successful products/applications

Supporting mission critical / business critical application for fortune500 customers

Providing continuous improvement against industry standards and

benchmark

36


37/88

Application Migration & Modernization

Studies show that over 70% applications of the world are still on

Mainframe and Legacy systems, and most businesses are in a

desperate need to modernize and upgrade their IT applications

environment. Zensar's Application Migration, Re-engineering &

Modernization services help customers to modernize and migrate from

older platforms to newer ones with minimum risks. Zensar has

effectively modernized legacy applications by improving operational

efficiency, reducing the cost of doing business and improving

information assets. We have a proven track record of successfully

modernizing large mission-critical mainframe and legacy system

projects for Fortune 500 clients.

Embedded Software:

Embedded Software in Zensar is focused on design and development

in the areas of computing systems(PC's and Servers), Networking and

Datacom, Peripherals, Storage devices and systems, Mobile and

multimedia applications & systems. We also specialize in

development of automated testing tools for hardware and software

products and systems in the systems and embedded software space.

Completing the entire ecosystem of embedded software services there

is a verification and validation of products and systems for

specification conformance, performance and inter-operability. Our

37


38/88

host of embedded software services applies to Product

Conceptualization and Development, Design Verification, Mass

Production and Maintenance.

Product Engineering

Zensar has a template based approach to implement processes in rapid

product life cycles. Innovations likeSolution BluePrint help in

improving productivity, creating value and leading to a model driven

approach to software product engineering services. Zensar during its

long experience in providing software product engineering services

has worked closely with ISVs like Informix, Microsoft and Fujitsu.

With development experience in multiple products and components

ranging from back end retailing solution, story creation product,

middleware components and drivers for database, Zensar also has

implementation experience in creating a language independent -

platform independent - database independent programming library for

its customers. With product development life cycle being highly

changeable and time to market increasingly becoming shorter,

mechanisms like agile development and the iterative models are

essential component in software product engineering services at

Zensar. This learning has also led to advanced services around

technology refresh and on-demand models (SaaS).

With our metrics driven approach, we can set performance targets,

measure the performance and consistently show improvement. The

extended team approach gives complete visibility and control to the

customer. Our methodology involves a phased approach:]

38
http://www.solution-blueprint.com/http://www.solution-blueprint.com/


39/88

Independent Testing Services

Dont let cost of poor quality burn your margins. Adopt independent

testing!

Software testing plays a pivotal role in program assurance. The impact

of the cost of poor quality is experienced only after systems go into

production and is rarely considered before or during program

implementation.

Software testing has evolved into a very mature discipline and is a

vital business-enabling function within any organization undertaking

critical transformation programs. Software testing plays a crucial role

in program assurance activities, helps achieve lean IT operations,

provides business enablement and also control the Total Cost of

Ownership (TCO).

Zensar has setup a Testing Centre of Excellence to drive the adoption

of a disciplined approach towards testing from a quality control and

assurance perspective. Our processes and frameworks assist in the

extremely efficient conduct of software testing. Enabled by

organization level baselines and best practices, Zensars testing

practice focuses on end user needs. Our test lab services incubate new

solutions to meet emerging industry trends and with a plethora of both

licensed and open source tools, we are able to suggest the most

appropriate solution bases on customer needs.

39


40/88

Service Offerings

Methodology

Our investment in building reusable test assets translates into immediate

benefits to the customer, in terms of increased efficiency and shorter time to

market. Our ready made test assets in Oracle Applications, Insurance, Retail

domains provide head start in testing projects.

Standardized test and defect management processes are followed

Reusable test artifacts are created and managed

Improvements are driven by metrics data gathering and analysis

Best Practices

Our test lab is involved in tool based technology development and has

indigenously developed the following tools/frameworks:

40


41/88

Robust, extensible Test Automation Framework (450 reusable

functional libraries)

Pre-Processor to reduce automation tool licenses for script

development

Tzen - Zensar's Test Management Tool (Platform independent, Cost

effective, Fully customizable, Extendible, Integration possibilities with

Open Source Testing Tool Mantis)

Risk Based Testing methodology

Automated test case generation from use cases using Zensars SBP

(Solution Blueprint)

Value Proposition

Ready availability of certified testing practitioners for deployment with

customer projects

State of the art test lab with licensed (IBM, HP etc), Open Source

(OpenSTA, Jameleon) tools

Ready made Test automation framework supporting Oracle Apps,

Java, .Net and Web applications for a head start

IP solutions 'Automation Preprocessor' for immediate implementation

in test automation without application software being available

Testing team with domain knowledge in Financial and Insurance

Services, Retail, Manufacturing, Energy and Utilities, Shipping,Logistics and Oracle Applications

Zensar's own test management tool (TZen) for productivity

improvements

41


42/88

Insurance

In today's scenario, Insurers face issues like globalization, growing demand

for web based services, regulatory demands, security threats and outsourcing.

We understand the needs of the industry and offer Innovative Solutions

which are unique, optimal and customer focused. Through a unique blend of

domain knowledge, technology and robust processes we have successfully

provided solutions to our leading Insurance Customers who faced challenges

like

Demanding business need for new, innovative applications in the

shortest possible time

Striking balance between new technology adoption and the legacy

environments

Long term plan for Application Integration, re-engineering and

retirement

Application and infrastructure maintenance

Availability of skilled resources Managing dynamic regulatory compliances in the legacy environment

42


43/88

Service Offerings for Insurance

We provide end-to-end IT services and solutions helping insurers in achieve

operational excellence, exceed customer expectations, faster time-to-market,

while driving their top-line revenue growth.

Application

Development & Maintenance Services

We offer cost effective solutions using our dual shore, onshore, near shore,

offshore delivery methodologies. Backed by our strong processes for

Application Support, Development and Legacy Transformation, our core

competencies lie in the functional areas of

New Business and Underwriting Systems

Policy Administration and Claims Processing

Agency Management Systems

Insurance Distribution Channel Management

Web enablement/Development of websites

Development of front-end applications to Legacy Systems

43


44/88

Finance and Accounting

Regulatory Compliance

Testing Services

We provide end-to-end testing services to the Insurance Industry to ensure

faster time-to-market by utilizing our test assets like library of test cases for

the Insurance Industry, automation of test scenarios, and host of in-house

developed tools. Our suites of testing services include functional testing,

operational acceptance testing, security testing and performance testing.

Consultancy Services

We provide consultancy in the areas of Enterprise Architecture, Design

Architecture, Data Migration, Usability Engineering for B2B/B2C websites,

Offshore Advisory services, Packaged Solution and Process implementation

services. We also provide IT staff augmentation services to Insurers who

look for specific skills and profiles.

Business Intelligence

Having provided end-to-end BI solutions for several Global Insurance

Organizations, we have been able to develop the expertise required to help

Insurance companies achieve performance excellence with custom-made BI

Insurance Solutions. Our solutions encompass every critical function that

needs monitoring to improve the overall productivity and profitability of an

Insurance Organization. These industry centric solutions, along with our

Strategic Business Intelligence Framework provide the BI Excellence, which

is the key to Enterprise Performance Management. Zensar's Business

44


45/88

Intelligence and Data Warehousing Solutions for the Insurance Industry

include Channel & Product Profitability, Underwriting and Claims

Intelligence, Broker and Delegated Billing Entities Intelligence, Finance,

Sales Force Performance Management and Customer Service Analytics

Banking

Banking and Financial Services Practice at Zensar is built on the strength of

four core competencies - Domain, Process, Technology and Innovation. The

practice is boosted by a myriad of activities like industry research and trends,

tools evaluation, continuous process optimization, innovation leading to

intellectual property, publishing white papers and capturing experiences in

the form of best practices and case studies.

Zensar's Banking and Financial Services Practice addresses the needs of

clients by leveraging its rich industry experience and deep technology

expertise. Our highly qualified team engages with clients to help them

implement sustainable business strategies while maintaining cost efficiencies

and thereby, gain competitive advantage in their marketplaces. Through a

network of alliances and partnerships, we provide true end-to-end business

transformation services to our clients.

Service Offerings in Banking

The bouquet of our service offerings cut across various horizontals like

application development, modernization and migrations, support and

maintenance and high-end consulting in major industry segments including

Retail Banking, Private Banking and Wealth Management, Capital Markets,

Compliance and Risk Management

45


46/88

Innovative Framework - Solution Blue-Print (SBP)

SBP is an in-house developed technology framework that facilitates and

simplifies the development and maintenance of software thus reducing costs

and improving productivity through process automation

Significant ROI is realized by the utilization and reuse of pre-built

models from the Enterprise Repository

Solution BluePrint are platform agnostic, thus enabling the

development of multi-platform deployable solutions whenever needed

Global Distributed Delivery Model

Process innovation fueled by an impeccable track record for

providing solutions to both public sector and the private sector globally

has resulted in Zensar's Global Delivery Platform (GDP) and thus

providing for collaborative solution delivery across shores and

46


47/88

entities seamlessly. This also enables Zensar to provide solutions to

customer on "Opti-shore delivery model" across multiple

geographies, often tailored to suit individual customer

requirements.

Lower cost of implementation /maintenance, faster time-to-market,

ready pool of trained and qualified professionals, and flexible staffing

with increased agility for ramp-up/down

Functionality Readiness Matrix

Overview

Helps client achieve set targets of time-to-Market for the

Product/Service offering

Facilitates risk based testing and gives client optimum Quality in given

time

Assurance of reliable application roll out mitigating risk to Brand

Image and Business (Revenue) Opportunity without compromising

Quality

Strike balance between Time and Quality with optimum cost

Identification of Functional Reliability and Business Risks

Goal/Target setting for mitigating identified risks, test completeness

and defect resolution

Continuous data feeds from external processes like Test Status

Reports, Traceability Matrix, Defect Status reports, Project

Management Plans etc for decision making (Dynamic and periodical)

Providing Client and Project management with a "big picture" view of

status

47


48/88

Energy and Utilities

Energy and Utilities (E & U) practice of Zensar possesses deep domain

expertise and exposure to Global Utility markets backed by 15 years of

hands on experience in the Industry's core technologies. E & U practice has

participated in the regulation and deregulation journey of the energy markets

and is actively assisting customers in achieving their goals and objectives.

E & U practice has acquired, expertise in the entire value chain of Energy &

Utilities industry's upstream, mid-stream, down-stream sectors and back

office operations with cumulative experience of 150+ projects and

over15000+ person years.

Upstream

Transmission Outage and Generation Availability,

Asset Management and Maintenance

Inventory Control

Fuel management

Midstream

Network Analysis, MIMS

Balancing Mechanism

Integrated Energy Management BETTA

Mains Risk Priority Management

SCADA GIS

Downstream

Emergency Meter Work

48


49/88

Job Issue System

Demand Derivation system

Field Force Device Replacement,

Connections work management & AMR,

Market Intelligence & Provision of Information

Back Office Operations

Knowledge Management

Enterprise Collaboration

EUC Applications Infrastructure Management

ERP

Service Offerings

Energy and Utilities practice has been providing the following services in

Analyzing and implementing regulatory and de regulatory changes, Legacy

Systems, Business process alignment and IT system improvements, Rapid

Application development to drive business benefits, Regulatory reporting ,

Program Assurance, Performance management, Application separation, and

consolidation due to deregulation or mergers and Acquisition, System

Integration and Green IT services We specialize in Advanced Meter

Management and Energy trading with our framework based solution, for

prototype and POC based implementation. We have local market experts as

partners for European and Indian markets.

49


50/88

Best Practices

Market Study: Understanding of the history, back ground , impacts and

future of regulations and de-regulations in UK. Participated in handling

innumerous IT system impacts due to regulation and de-regulations

FOMSA Exit (Front office system separation)

SOMSA Exit (System Operation Systems separation)

Separation of IDNs and Interface building (Black water Program)

Connection unbundling

Regulatory reporting (Market Information provisioning projects)

Participation in RGTA / BETTA / TMA programs implementation.

Value Proposition

50


51/88

Framework based development for Energy Trading

Innovative way of bridging the gap between Industry and service

providers through Market based Advisory Councils.

Partnership with leading Utilities domain and market experts in

Europe to bring the Industry best practices and IT services

together. http://www.ucpartners.eu/

Energy and Utilities practice specializes in providing cutting edge

technology solutions in Automatic Meter Management (AMM), Asset

and Work Management , Energy Trading, Balancing Mechanism,

Field Force Automation, SOA based Energy Trading framework to

implement flexibility, re-usability and competitive strategy and

Integration of systems and processes to get STP.

Manufacturing

Globally manufacturing companies are undergoing a change. With

rising customer expectations and increasing competition generating

pressure on margins, companies are being pushed to innovate on new

products and services with increased operational complexity.

Companies cannot be run in the traditional way anymore. In this

competitive market only whose who control costs , invest on product

innovation and reduce time to market will surge ahead.

We believe that IT can be an enabler to create the culture change to

drive companies in that direction. We leverage on our range of

solutions and services to engage with the customer to be a true

'Transformation Partner'.

51
http://www.ucpartners.eu/http://www.ucpartners.eu/


52/88

With 200+ experienced consultants in different streams have engaged

in 50 over projects of diverse complexities. Our engagement ranges

from many fortune 500 companies engaged with us for long periods

upto 8-10 years which is deep and matured and also includes SMEs for

quick short cycle implementations as well.

We deliver enterprise class solution core to manufacturing and supply

chain and around all related services which are extremely critical to

make an IT enablement most effective as an end to end partner.

Consulting Services (Consulting Practice)

To help device IT enablement strategy based on organization's IT readiness

and future growth plans so IT can be used as true business transformation

tool.

Oracle ERP - Manufacturing and Supply Chain Implementation

SAP - Implementation Solution in manufacturing and supply chain

space

Product Development

Manufacturing Operations

Demand Driven Supply Chain - Demantra

Supply Chain Management

Reverse Logistics - Service Supply Chain

Business intelligence / Enterprise performance Management

In manufacturing and supply chain space

Customer Operations

52
http://www.zensar.com/industries_Oracle.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/industries_ProductDevelopment.htmlhttp://www.zensar.com/industries_ManufacturingOperations.htmlhttp://www.zensar.com/industries_DemandSupply.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/industries_ReverseLogistics.htmlhttp://www.zensar.com/industries_BusinessIntelligence.htmlhttp://www.zensar.com/BPO_CustomerInteraction.htmlhttp://www.zensar.com/industries_Oracle.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/industries_ProductDevelopment.htmlhttp://www.zensar.com/industries_ManufacturingOperations.htmlhttp://www.zensar.com/industries_DemandSupply.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/industries_ReverseLogistics.htmlhttp://www.zensar.com/industries_BusinessIntelligence.htmlhttp://www.zensar.com/BPO_CustomerInteraction.html


53/88

Improving customer experience in B2B , B2C and B2E mode by deploying

internal and external portals

Supply Chain Integrations

SOA and EAM - The initial pitch should be a business pitch without too

much technology.

BPO service in Supply Chain

Healthcare and Life Sciences

The healthcare and life sciences industry is seeing a rapid change across the

globe due to evolving research programs, technology advancement and

upcoming business models and frameworks. The entire gamut of the

healthcare & life sciences sector has become very data intensive, owing to

the mandatory and stringent regulatory enforcements leading to multiple

challenges in terms of providing more affordable treatment and better patient

care. The pressure to maintain huge volumes of data and the importance to

ensure accuracy and reliability of the data repository requires companies to

utilize technology in order to address the increasing demand of the industry.

Zensar Technologies helps healthcare and life sciences organizations to

increase operational efficiencies, reduce administrative and delivery cost,

and enhance patient health and wellness through patient-centric processes

and inter-operable methods.

Interoperability is the key between various service offerings. Through proven

technologies, industry best practices, and global delivery capabilities, we

provide high-quality healthcare and life sciences support solutions. By

53
http://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/BPO_KPO.htmlhttp://www.zensar.com/industries_SupplyChain.htmlhttp://www.zensar.com/BPO_KPO.html


54/88

leveraging our experience, we have developed technical expertise in

providing services like data integration and warehousing, business

intelligence and enterprise collaboration solutions, domain-specific

frameworks and business models, process outsourcing and many more.

Life Sciences

We help in structuring yourprocesses as you embark on your success story

of innovation from Molecule to Market.

Share our expertise - Our industry experts continuously keep an eye on

the industry standards & government regulations

Leverage our experience Our years of experience can prove to be

immensely beneficial in optimizing the lead times by accelerating the

product release process

Trust our confidence We have become proficient in understanding

the support requirements in the drug development processes, and thus

offer customized services for workflow management, tracking &

traceability, innovative marketing and design packages

54


55/88

INSURANCE

Insurance

In today's scenario, Insurers face issues like globalization, growing demand

for web based services, regulatory demands, security threats and outsourcing.

We understand the needs of the industry and offer Innovative Solutions

which are unique, optimal and customer focused. Through a unique blend of

domain knowledge, technology and robust processes we have successfully

provided solutions to our leading Insurance Customers who faced challenges

like

Demanding business need for new, innovative applications in the

shortest possible time

Striking balance between new technology adoption and the legacy

environments

Long term plan for Application Integration, re-engineering and

retirement

Application and infrastructure maintenance

Availability of skilled resources

Managing dynamic regulatory compliances in the legacy environment

55
http://www.zensar.com/insurancehttp://www.zensar.com/insurance


56/88

Service Offerings

We provide end-to-end IT services and solutions helping insurers in achieve

operational excellence, exceed customer expectations, faster time-to-market,

while driving their top-line revenue growth.

Banking

Banking and Financial Services Practice at Zensar is built on the strength of

four core competencies - Domain, Process, Technology and Innovation. The

practice is boosted by a myriad of activities like industry research and trends,

tools evaluation, continuous process optimization, innovation leading to

intellectual property, publishing white papers and capturing experiences in

the form of best practices and case studies.

Zensar's Banking and Financial Services Practice addresses the needs of

clients by leveraging its rich industry experience and deep technology

expertise. Our highly qualified team engages with clients to help them

implement sustainable business strategies while maintaining cost efficienciesand thereby, gain competitive advantage in their marketplaces. Through a

network of alliances and partnerships, we provide true end-to-end business

transformation services to our clients.




Energy and Utilities (E & U) practice of Zensar possesses deep domain

expertise and exposure to Global Utility markets backed by 15 years of

hands on experience in the Industry's core technologies. E & U practice has

56


57/88

participated in the regulation and deregulation journey of the energy markets

and is actively assisting customers in achieving their goals and objectives.

E & U practice has acquired, expertise in the entire value chain of Energy &

Utilities industry's upstream, mid-stream, down-stream sectors and back

office operations with cumulative experience of 150+ projects and

over15000+ person years.

Upstream

Transmission Outage and Generation Availability,

Asset Management and Maintenance

Inventory Control

Fuel management

Midstream

Network Analysis, MIMS

Balancing Mechanism

Integrated Energy Management BETTA

Mains Risk Priority Management

SCADA

GIS

Downstream

Emergency Meter Work Job Issue System

Demand Derivation system

Field Force Device Replacement,

Connections work management & AMR,

57


58/88

Market Intelligence & Provision of Information

Back Office Operations

Knowledge Management

Enterprise Collaboration

EUC Applications

Infrastructure Management

ERP

58


59/88

MANUFACTURING

Manufacturing

Globally manufacturing companies are undergoing a change. With rising

customer expectations and increasing competition generating pressure on

margins, companies are being pushed to innovate on new products and

services with increased operational complexity. Companies cannot be run in

the traditional way anymore. In this competitive market only whose who

control costs , invest on product innovation and reduce time to market will

surge ahead.

We believe that IT can be an enabler to create the culture change to drive

companies in that direction. We leverage on our range of solutions and

services to engage with the customer to be a true 'Transformation Partner'.

With 200+ experienced consultants in different streams have engaged in 50

over projects of diverse complexities. Our engagement ranges from manyfortune 500 companies engaged with us for long periods upto 8-10 years

which is deep and matured and also includes SMEs for quick short cycle

implementations as well.

We deliver enterprise class solution core to manufacturing and supply chain

and around all related services which are extremely critical to make an IT

enablement most effective as an end to end partner.

SAP

Zensar offers innovative and cost effective Manufacturing solutions in SAP.

The pre-configured industry solution mySAP All-in-One for the

59


60/88

Manufacturing Industry, addresses typical business challenges prevailing in

this segment. A more focused pre-configured offering OBTEngg is an

integrated solution that covers complete business processes needs of the

Manufacturing industry like Machine Building, Fabrication, Component

Manufacturing OEM, Component Manufacturing Replacements and Design

and Development. Both these solution has enable us to offer high quality

solution at affordable costs on a fixed time and cost basis. As a one-stop SAP

Solution Provider, ZensarOBT offers turnkey solution consisting of SAP

Licenses, Computer Hardware, Implementation, and Annual Maintenance to

all its clientele.

OBTEngg, offers comprehensive business functionalities with a ready-to-use

reporting system, which also complies with regulatory principles. The

solution can be implemented in little over 75 days, which means Faster

Return on Investment. OBTEngg reduces the implementation time drastically

while maintaining all the required functionality. Typical features of this

product include:

Integrated Solution for Design, Pilot launch and stabilization.

Variant configuration to facilitate complex product manufacturing.

Complete solution of contract manufacturing.

Quality assurance and monitoring based on customer and Vendor

specific quality plans.

SPC monitoring for process improvements.

On-line OEE and NEE calculation for quick and effective feedback for

the management to take necessary improvement measures.

60


61/88

Preventive and Break down maintenance of machineries and

Production resource tools.

Effective solutions with Document management system coupled with

Manufacturing change management for Monitoring design changes.

Export management system with all the statutory documents required.

Business Intelligence

The Manufacturing world's most critical need is the ability to get a single

enterprise view of end to end enterprise information from vendors/ suppliers

to customers in order to fuel the realization of investments made in

information technology. Our BIDW practice provides custom-made solutions

for the manufacturing industry, with a special focus on High Tech, Consumer

Electronics and Traditional Manufacturing corporations. Having provided

end-to-end BI solutions for several Global Manufacturing Conglomerates,

we have developed the expertise required to help Manufacturing companies

achieve performance excellence in an increasingly challenging and complex

industry scenario.Our solutions for this sector encompass every mission critical function that

needs monitoring to improve the overall profitability of the Manufacturing

Organisation. These industry centric solutions, along with our Strategic

Business Intelligence Framework provide the BI Excellence, which is the

key to Enterprise Performance Management. Zensar's Business Intelligence

& Data Warehousing Solutions for the Manufacturing Industry include,

Inbound Logistics, Planning and Production, Sales and Marketing,Finance,

Human Resources and After Sales Services.

61


62/88

Over The Counter Products

India continues to hold a significant pharmaceutical market potential, not

least due to its large and rapidly expanding population. Prescription drugs

account for around two-thirds of the total market, with over-the-counter

(OTC) products likely to benefit from the liberalisation of retail channels

anticipated during the forecast period. Generics represent less than 40% of

the market by value, although intellectual property (IP) regime shortcomings

allow for the production and use of counterfeit drugs. India's imports of

medicines are expected to overtake its exports, resulting in a trade deficit of

US$300mn by 2010, although foreign acquisitions by large domestic generic

manufacturers will boost exports of cheaper drugs. The Indian drug sector

remains highly competitive, with the state pricing policy continuing to stifle

growth and the new drug patent law set to increase foreign company activity.

BMI expects the pharmaceutical sector to grow by some 8% in 2006, behind

the country's major Asian rival, China. Sales are likely to exceed US$15.2bn

by 2010, with annual growth at around 9%. The growth of 'civilisation'

diseases, boosted by changing demographics and rising healthcare

expectations, will simulate the need for cardiovascular, neurological,

metabolic and cancer drugs in particular. The treatment of infective diseases,

especially hepatitis and HIV/AIDS, will necessitate supplies from abroad,

while simultaneously encouraging local research and development (R&D)

activities in this direction. Expected liberalisation of over-the-counter (OTC)

medicine sales channels will in the short term result in shrinking profits, but

in the longer term boost the sector's performance. However, the expected

62


63/88

price cuts will have a significant negative effect on all sectors of the industry

and its commitment to local R&D and future launches, while potentially

boosting trade in counterfeits.

In regional terms, India will outperform a number of its neighbours, boosted

by its ongoing industrial development, foreign direct investment and

overseas activities. However, IP and pricing problems will continue to hinder

pharmaceutical sector growth over the coming years. Indeed, the government

is planning to reduce the prices of approximately 8% of all drugs sold in the

country, with the most expensive treatments receiving the largest cuts.

Nevertheless, BMI's adjusted Business Environment Rankings for Asia place

India in sixth place, behind China.

Indian firms continue to expand in advanced markets, both through outright

acquisitions of overseas facilities and generic product approvals in advanced

markets. Most recently, Venus Remedies has secured a deal to export its

oncology products to Ukraine. International companies remain interested in

the Indian market, which is developing due to population growth, as well as

improvements in economic conditions and patent law. Consequently, new

launches will become a more frequent occurrence. US-based Bristol-Myers

Squibb has recently introduced Baraclude to meet the rising, but as yet

unmet, medical need for chronic hepatitis B treatment in India.

Countries covered: India

India continues to hold a significant pharmaceutical market potential, not

least due to its large and rapidly expanding population. Prescription drugs

account for around two-thirds of the total market, with over-thecounter

(OTC) products likely to benefit from the liberalisation of retail channels

63


64/88

anticipated during the forecast period. Generics represent less than 40% of

the market by value, although intellectual property (IP) regime shortcomings

allow for the production and use of counterfeit drugs. Indias imports of

medicines are expected to overtake its exports, resulting in a trade deficit of

US$300mn by 2010, although foreign acquisitions by large domestic generic

manufacturers will boost exports of cheaper drugs. The Indian drug sector

remains highly competitive, with the state pricing policy continuing to stifle

growth and the new drug patent law set to increase foreign company activity.

BMI expects the pharmaceutical sector to grow by some 8% in 2006, behind

the countrys major Asian rival, China. Sales are likely to exceed US$15.2bn

by 2010, with annual growth at around 9%. The growth of civilisation

diseases, boosted by changing demographics and rising healthcare

expectations, will simulate the need for cardiovascular, neurological,

metabolic and cancer drugs in particular. The treatment of infective diseases,

especially hepatitis and HIV/AIDS, will necessitate supplies from abroad,

while simultaneously encouraging local research and development (R&D)

activities in this direction. Expected liberalisation of over-the-counter (OTC)

medicine sales channels will in the short term result in shrinking profits, but

in the longer term boost the sectors performance. However, the expected

price cuts will have a significant negative effect on all sectors of the industry

and its commitment to local R&D and future launches, while potentially

boosting trade in counterfeits.

In regional terms, India will outperform a number of its neighbours, boosted

by its ongoing industrial development, foreign direct investment and

64


65/88

overseas activities. However, IP and pricing problems will continue to hinder

pharmaceutical sector growth over the coming years. Indeed, the government

is planning to reduce the prices of approximately 8% of all drugs sold in the

country, with the most expensive treatments receiving the largest cuts.

Nevertheless, BMIs adjusted Business Environment Rankings for Asia place

India in sixth place, behind China.

Indian firms continue to expand in advanced markets, both through outright

acquisitions of overseas facilities and generic product approvals in advanced

markets. Most recently, Venus Remedies has secured a deal to export its

oncology products to Ukraine. International companies remain interested in

the Indian market, which is developing due to population growth, as well as

improvements in economic conditions and patent law. Consequently, new

launches will become a more frequent occurrence. US based Bristol-Myers

Squibb has recently introduced Baraclude to meet the rising, but as yet

unmet, medical need for chronic hepatitis B treatment in India

Ranbaxy Q1 2007 Net Profit Rises 79% to Rs.129 Crores

Operating profit before tax doubles (Rs 1,597 Mn, up 100%); Consolidated

Revenues at Rs.15,644 Mn; up 23% compared to corresponding quarter.

65


66/88

Generic: Amlodipine

VAMLO Ranbaxy Global Consumer Healthcare

Tablet 2.5 mg 10 Rs: 12.45

Tablet 5 mg 10 Rs: 17.95


Generic: Amlodipine + Losartan Potassium

COVAMLO Ranbaxy Global Consumer Healthcare

Tablet 10 Rs: 67.5

Generic: Aspirin (Low Dose)

ASPENT Ranbaxy Global Consumer Healthcare

Tablet 60 mg 14 Rs: 9

Generic: Atorvastatin

STORVAS Ranbaxy Global Consumer Healthcare




Generic: Candesartan

CANDESAR Ranbaxy Global Consumer Healthcare




Generic: Carvedilol

CASLOT Ranbaxy Global Consumer Healthcare

Tablet 12.5 mg 10 Rs: 30





Generic: Celiprolol

66


67/88

CELIPRES Ranbaxy Global Consumer Healthcare


Tablet 200 mg 10 Rs: 51.15

Generic: Clopidogrel

CERUVIN Ranbaxy Global Consumer Healthcare


Generic: Dextromethorphan

CHERICOF LOZENGES Ranbaxy Global Consumer Healthcare

Lozenges 5 mg 8 Rs: 21

Generic: Esomeprazole

RACIPER Ranbaxy Global Consumer Healthcare



Generic: Fenofibrate

STANLIP Ranbaxy Global Consumer Healthcare


Generic: Finasteride

FINARA Ranbaxy Global Consumer Healthcare


Generic: GlimepirideGLIMPID Ranbaxy Global Consumer Healthcare




Generic: Losartan Potassium

COVANCE Ranbaxy Global Consumer Healthcare



67


68/88

Generic: Losartan Potassium + Hydrochlorothiazide

COVANCE-D Ranbaxy Global Consumer Healthcare

Tablet 10 Rs: 57

Generic: Metformin

RIOMET OD Ranbaxy Global Consumer Healthcare



Generic: Montelukast

ROMILAST Ranbaxy Global Consumer Healthcare



Tablet 10 mg 10 Rs: 149.95

ROMILAST GRANULES Ranbaxy Global Consumer Healthcare

Sachet 4 mg 1 Rs: 5.85

Generic:Montelukast +

Bambuterol

ROMILAST-B Ranbaxy Global Consumer Healthcare

Tablet 10 Rs: 69

Tablet 10 Rs: 104.6

Generic: PioglitazonePIOGLAR Ranbaxy Global Consumer Healthcare



Generic: Quetiapine Fumarate

SOCALM Ranbaxy Global Consumer Healthcare




68


69/88

Generic: Rabies Immunoglobulin

IMOGAM RABIES Ranbaxy Global Consumer Healthcare

Vial 300 i.u. 2ml Rs: 3900

Generic: Rabies Vaccine

VERORAB Ranbaxy Global Consumer Healthcare

Vial 0.5ml Rs: 304

Generic: Ramipril

CORPRIL Ranbaxy Global Consumer Healthcare

Capsule 1.25 mg 10 Rs: 15

Capsule 2.5 mg 10 Rs: 40

Capsule 5 mg 10 Rs: 56.9

Generic: Ramipril + Amlodipine

CORPRIL AM Ranbaxy Global Consumer Healthcare

Tablet 10 Rs: 45

Generic: Simvastatin + Nicotinic acid

SIMVOTIN Ranbaxy Global Consumer Healthcare




Generic: Tadalafil

FORZEST Ranbaxy Global Consumer Healthcare



Generic: Tolterodine Tartarate

ROLITEN Ranbaxy Global Consumer Healthcare



Generic: Valsartan

69


70/88

STARVAL Ranbaxy Global Consumer Healthcare

Capsule 80 mg 10 Rs: 69

Capsule 160 mg 10 Rs: 130

70


71/88

RESEARCH METHODOLOGY

Sample - Size = 100 Questionnaire

Target Group -

SEC ABCDE

Age Group : 21 + years

Male and female

Users of Zensar and competition brands

Non users of category

Minimum quotas will be ensured for

- Zensar users

- Consumers who have seen Zensar advertising

1. Research Design:

A research design is a pattern or an outline of a research projects working. It is a

statement of only the essential elements of a study, those that provide the basic guidelines

for the details of the project. It comprises a series of prior decision that taken together

provide master plans for executing a research projects.A research design serves as a bridge between what ha

Project Report on Zensar Pharma

Documents

Transcript of Project Report on Zensar Pharma